AR016148A1 - DERIVATIVES OF BIFENYLL, PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT. - Google Patents
DERIVATIVES OF BIFENYLL, PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.Info
- Publication number
- AR016148A1 AR016148A1 ARP980105469A ARP980105469A AR016148A1 AR 016148 A1 AR016148 A1 AR 016148A1 AR P980105469 A ARP980105469 A AR P980105469A AR P980105469 A ARP980105469 A AR P980105469A AR 016148 A1 AR016148 A1 AR 016148A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- alkoxy
- hydrogen
- independently
- manufacture
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
Derivados de bifenilo que tienen propiedades anti-convulsivas y neuroprotectoras de la formula I: en donde R1 y R2, independientemente, son hidrogeno,alquilo C1-4, alcoxi C1-4, tioalquilo C1-4, halngeno, trifluorometilo, trifluorometoxi, ciano oalca noílo C2-5, R3 es hidrogeno, hidroxi, alquilo C1-4, alcoxiC1-4, ciclolquiloxi C3-6, halogeno, ciano, alcanoílo C2-5, carbamoílo, alquilo C1-4-sulfoniloxi o trifluorometilsulfoniloxi, R4 es hidrogeno, hidrogri o alcoxiC1-4, y R5 es un grupo dela form ula (a), (b), (c) o (d) en donde: R6 es alquilo C1-4, X es una cadena de alquileno recta o ramificada con C1-4, y R7 y R8,independientemente, son hidrogeno, alquilo C1-4, hidroxialquilo C2-4, o fenilalquilo C1-4, o forman, junto con elátomo de nitr ogeno con el que están unidos,un grupo pirrolidinilo, piperidino, piperazinilo o morfolino, o un grupo de la formula (e): en donde Z es O, CH2 o CH2-CH2, y R9, R10, R11, R12, R13 y R14,independientemente, son H, halogeno, alquilo C1-4,o alcoxi C1-4, en forma de base libre o de sal de adicion de ácido, proceso para su produccion, composicionfarmacéutica que los contiene y su uso para la manufactura de un medicamento. Utiles para la epilepsia y estados convulsivos.Biphenyl derivatives having anti-seizure and neuroprotective properties of formula I: wherein R1 and R2, independently, are hydrogen, C1-4 alkyl, C1-4 alkoxy, C1-4 thioalkyl, halngene, trifluoromethyl, trifluoromethoxy, cyano oalca C2-5, R3 is hydrogen, hydroxy, C1-4 alkyl, C1-4 alkoxy, C3-6 cycloolkyloxy, halogen, cyano, C2-5 alkanoyl, carbamoyl, C1-4-sulfonyloxy alkyl or trifluoromethylsulfonyloxy, R4 is hydrogen, hydrorogri or C1-4 alkoxy, and R5 is a group of the form (a), (b), (c) or (d) where: R6 is C1-4 alkyl, X is a straight or branched alkylene chain with C1- 4, and R7 and R8, independently, are hydrogen, C1-4 alkyl, C2-4 hydroxyalkyl, or C1-4 phenylalkyl, or together with the nitrogen atom lathomene with which they are attached, a pyrrolidinyl, piperidine, piperazinyl group or morpholino, or a group of the formula (e): wherein Z is O, CH2 or CH2-CH2, and R9, R10, R11, R12, R13 and R14, independently, are H, halogen, C1-4 alkyl, or C1 alkoxy -4, in the form of free base or acid addition salt, process for its production, pharmaceutical composition containing them and its use for the manufacture of a medicine. Useful for epilepsy and seizure states.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9723133.6A GB9723133D0 (en) | 1997-11-03 | 1997-11-03 | Organic compounds |
GBGB9723134.4A GB9723134D0 (en) | 1997-11-03 | 1997-11-03 | Organic compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016148A1 true AR016148A1 (en) | 2001-06-20 |
Family
ID=26312535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980105469A AR016148A1 (en) | 1997-11-03 | 1998-10-30 | DERIVATIVES OF BIFENYLL, PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT. |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1037876A1 (en) |
JP (1) | JP2001521923A (en) |
KR (1) | KR20010031699A (en) |
CN (1) | CN1278249A (en) |
AR (1) | AR016148A1 (en) |
AU (1) | AU740448B2 (en) |
BR (1) | BR9813897A (en) |
CA (1) | CA2308151A1 (en) |
CO (1) | CO5011067A1 (en) |
ID (1) | ID24413A (en) |
IL (1) | IL135580A0 (en) |
NO (1) | NO20002321D0 (en) |
NZ (1) | NZ503815A (en) |
PE (1) | PE123599A1 (en) |
PL (1) | PL339922A1 (en) |
SK (1) | SK6412000A3 (en) |
TR (1) | TR200001122T2 (en) |
WO (1) | WO1999023073A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6858592B2 (en) | 2001-06-29 | 2005-02-22 | Genzyme Corporation | Aryl boronic acids for treating obesity |
US7041280B2 (en) | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
TW200840566A (en) * | 2006-12-22 | 2008-10-16 | Esteve Labor Dr | Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments |
WO2010059393A1 (en) | 2008-10-30 | 2010-05-27 | Janssen Pharmaceutica Nv | Serotonin receptor modulators |
US8575364B2 (en) | 2008-10-30 | 2013-11-05 | Janssen Pharmaceutica Nv | Modulators of serotonin receptor |
DE102009015697A1 (en) | 2009-03-31 | 2010-10-07 | Markus Dr. Heinrich | Process for the arylation of ring-substituted phenols and phenyl ethers |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2114122A (en) * | 1938-04-12 | Alcohols and process fob making | ||
DE674968C (en) * | 1935-01-15 | 1939-04-26 | Roehm & Haas Company | Process for the preparation of phenolic aralkylamino alcohols |
US2040039A (en) * | 1935-02-26 | 1936-05-05 | Rohm & Haas | Phenolic morpholines |
US2485550A (en) * | 1946-06-25 | 1949-10-25 | Hoffmann La Roche | Quaternary salts of carbamic acid esters of tertiary-hydroxybenzyl-amines |
US2493710A (en) * | 1947-03-21 | 1950-01-03 | Hoffmann La Roche | Carbamic acid esters |
US2872477A (en) * | 1957-04-05 | 1959-02-03 | Dow Chemical Co | alpha-(dialkylamino)-6-phenyl-o-cresol esters |
JPS5328150A (en) * | 1976-08-25 | 1978-03-16 | Sugai Chemical Ind Co Ltd | Novel orthophenyl phenol derivative process for preparing same |
US5053548A (en) * | 1989-02-08 | 1991-10-01 | Otsuka Pharmaceutical Company, Ltd. | Biphenyl derivative composition for nerve cell degeneration repairing or protective agent and process for preparing a phenyl derivative contained in the composition |
US5428037A (en) * | 1993-04-09 | 1995-06-27 | Syntex Pharmaceuticals, Ltd. | Heterocyclic derivatives in the treatment of Ischaemia and related diseases |
JPH072655A (en) * | 1993-06-18 | 1995-01-06 | Otsuka Pharmaceut Co Ltd | Agent for repairing or protecting denaturation of peripheral nerve |
EP1123933A1 (en) * | 1994-10-14 | 2001-08-16 | MERCK PATENT GmbH | 2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]chromane as CNS active agent |
EP0793662A1 (en) * | 1994-11-23 | 1997-09-10 | Neurogen Corporation | Aminomethyl aryl compounds; dopamine receptor subtype selective ligands |
IL116249A (en) * | 1994-12-12 | 2003-07-06 | Pfizer | Nk-1 receptor antagonists for the treatment of neuronal damage and stroke |
DE19637237A1 (en) * | 1996-09-13 | 1998-03-19 | Merck Patent Gmbh | Piperazine derivatives |
-
1998
- 1998-10-29 CO CO98063635A patent/CO5011067A1/en unknown
- 1998-10-30 EP EP98958884A patent/EP1037876A1/en not_active Withdrawn
- 1998-10-30 CA CA002308151A patent/CA2308151A1/en not_active Abandoned
- 1998-10-30 IL IL13558098A patent/IL135580A0/en unknown
- 1998-10-30 SK SK641-2000A patent/SK6412000A3/en unknown
- 1998-10-30 ID IDW20000790A patent/ID24413A/en unknown
- 1998-10-30 TR TR2000/01122T patent/TR200001122T2/en unknown
- 1998-10-30 BR BR9813897-9A patent/BR9813897A/en not_active IP Right Cessation
- 1998-10-30 AU AU14872/99A patent/AU740448B2/en not_active Ceased
- 1998-10-30 CN CN98810761A patent/CN1278249A/en active Pending
- 1998-10-30 KR KR1020007004762A patent/KR20010031699A/en not_active Application Discontinuation
- 1998-10-30 WO PCT/EP1998/006880 patent/WO1999023073A1/en not_active Application Discontinuation
- 1998-10-30 PL PL98339922A patent/PL339922A1/en unknown
- 1998-10-30 NZ NZ503815A patent/NZ503815A/en unknown
- 1998-10-30 JP JP2000518948A patent/JP2001521923A/en active Pending
- 1998-10-30 AR ARP980105469A patent/AR016148A1/en not_active Application Discontinuation
- 1998-11-02 PE PE1998001034A patent/PE123599A1/en not_active Application Discontinuation
-
2000
- 2000-05-02 NO NO20002321A patent/NO20002321D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ID24413A (en) | 2000-07-20 |
JP2001521923A (en) | 2001-11-13 |
EP1037876A1 (en) | 2000-09-27 |
CA2308151A1 (en) | 1999-05-14 |
NZ503815A (en) | 2002-05-31 |
NO20002321L (en) | 2000-05-02 |
AU740448B2 (en) | 2001-11-01 |
PE123599A1 (en) | 1999-12-20 |
SK6412000A3 (en) | 2000-09-12 |
TR200001122T2 (en) | 2000-08-21 |
KR20010031699A (en) | 2001-04-16 |
CN1278249A (en) | 2000-12-27 |
PL339922A1 (en) | 2001-01-15 |
IL135580A0 (en) | 2001-05-20 |
CO5011067A1 (en) | 2001-02-28 |
AU1487299A (en) | 1999-05-24 |
WO1999023073A1 (en) | 1999-05-14 |
NO20002321D0 (en) | 2000-05-02 |
BR9813897A (en) | 2000-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20053454B (en) | Aryl Fused Azapolycyclic Compounds, Composition Containing the Same and Use Thereof | |
ES2114931T3 (en) | NEW STEROID ESTERS. | |
UY26957A1 (en) | NEW ANTI-POLYNERGIC AGENTS THAT CAN BE USED AS MEDICATIONS AS WELL AS PROCEDURE FOR PREPARATION | |
AR029463A1 (en) | DISPOSED PIRROLIDINS, A PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT | |
IL108786A0 (en) | 4-aminopyridines, processes for their production and pharmaceutical agents containing them | |
MX9207495A (en) | TETRAHYDROISOQUINOLINE COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
ES2187983T3 (en) | DERIVATIVES 1,2,3,4-TETRAHIDRONAFTALENO SUBSTITUTED. | |
AR061422A2 (en) | SELECTIVE CYCLE PEPTIDES, PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM, AND USE OF THEMSELVES IN THE PREPARATION OF MEDICINES | |
AR037517A1 (en) | DERIVATIVES OF NAFTIRIDINES, A PROCESS FOR THE PREPARATION, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AN INFLAMMATORY DISEASE | |
AR034282A1 (en) | DERIVATIVES OF DIFENYLAZETIDINONE, MEDICATIONS CONTAINING THESE COMPOUNDS, PROCEDURE FOR PREPARATION, AND ITS USE FOR THE PREPARATION OF MEDICINES | |
PA8518701A1 (en) | USEFUL THIOPHEN DERIVATIVES AS ANTI-TARGET AGENTS | |
SV2003000633A (en) | NEW TIADIAZOLS AND OXADIAZOLS AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASA-7 | |
AR029403A1 (en) | N-SUBSTITUTED DERIVATIVES OF CARBAMOILOXIALQUIL-AZOLIO, A PROCESS FOR ITS MANUFACTURE, PHARMACEUTICAL COMPOSITION AND THE USE OF THEM FOR THE PREPARATION OF A MEDICINAL PRODUCT | |
CO5560559A2 (en) | FORMULATION OF STABILIZED ORAL SUSPENSION | |
ES2150544T3 (en) | SHORT-ACTION DIHYDROPYRIDINES. | |
GEP20033118B (en) | Meta-Azacyclic Amino Benzoic Acid Compounds and Derivatives Thereof Being Integrin Inhibitors, Pharmaceutical Composition and Use Thereof | |
AR033803A1 (en) | DIANILINO ESCUARANO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM, AND THE USE OF THE SAME IN THE MANUFACTURE OF MEDICINES TO TREAT CHEMIOQUINE MEDIUM-RELATED DISEASES | |
ATE127452T1 (en) | POLY-4-AMINOPYRROLE-2-CARBOXAMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING SAME. | |
GEP20033052B (en) | Tricyclic Sulfonamides and Their Derivatives As Inhibitors of Matrix Metalloproteinases | |
AR016148A1 (en) | DERIVATIVES OF BIFENYLL, PROCESS FOR ITS PRODUCTION, PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT. | |
AR010809A1 (en) | COMPOUNDS DERIVED FROM AMINO PHOSPHONATES, A PROCEDURE FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITION THAT UNDERSTAND THEM, USE OF THE SAME FOR THE MANUFACTURE OF A MEDICATION USEFUL IN THE TREATMENT OF ARTERIOSCLEROSIS | |
AR012603A1 (en) | PROTEASE INHIBITOR, PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT; AND SYNTHESIS INTERMEDIARIES | |
AR017172A1 (en) | COMPOUNDS DERIVED FROM 3,4-DIARILTIAZOLINA-2-ONA OR 2-TIONA A METHOD FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND | |
MX9400253A (en) | DERIVATIVES OF PIPERAZINE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
AR008331A1 (en) | ANTAGONIST COMPOUNDS OF AN IL-8 RECEPTOR, USE OF THE SAME FOR THE MANUFACTURE OF MEDICINES, PROCEDURE FOR THEIR OBTAINING, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |